Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis
Introduction: Chronic kidney disease (CKD) is a global health concern, but the current treatments only slow down the progression. Thus an improved understanding of the pathogenesis and novel treatments of CKD are needed. The nephrotoxic nephritis (NTN) model has the potential to study the pathogenes...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-10-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/0886022X.2018.1533867 |
id |
doaj-701acb5708c44b139971b36d0df7cd86 |
---|---|
record_format |
Article |
spelling |
doaj-701acb5708c44b139971b36d0df7cd862020-11-25T01:46:26ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492018-10-0140164064810.1080/0886022X.2018.15338671533867Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritisM. E. Ougaard0H. E. Jensen1I. D. Thuen2E. G. Petersen3P. H. Kvist4Novo NordiskUniversity of CopenhagenUniversity of CopenhagenUniversity of CopenhagenNovo NordiskIntroduction: Chronic kidney disease (CKD) is a global health concern, but the current treatments only slow down the progression. Thus an improved understanding of the pathogenesis and novel treatments of CKD are needed. The nephrotoxic nephritis (NTN) model has the potential to study the pathogenesis of CKD as it resembles human CKD. The classical treatments with angiotensin II receptor blocker (ARB) or the angiotensin-converting enzyme inhibitor (ACE I) have shown a clinical effect in CKD. Methods: We characterized the disease development in the NTN model over 11 weeks by investigating functional and histopathological changes. We tested doses of 15 and 30 mg/kg/day enalapril and losartan in the NTN model in order to investigate the effect of inhibiting the renin-angiotensin-system (RAS). Results: The NTN model displayed albuminuria peaking on days 6–7, mesangial expansion (ME), renal fibrosis, inflammation and iron accumulation peaking on day 42. However, albuminuria, ME, renal fibrosis and inflammation were still significantly present on day 77, suggesting that the NTN model is useful for studying both the acute and chronic disease phases. Enalapril and losartan significantly enhanced the glomerular filtration rate (GFR) and decreased albuminuria, ME, renal fibrosis and inflammation of NTN-induced kidney disease in mice. Conclusions: This is the first study showing a comprehensive pathological description of the chronic features of the murine NTN model and that inhibiting the RAS pathway show a significant effect on functional and morphological parameters.http://dx.doi.org/10.1080/0886022X.2018.1533867Nephrotoxic serum nephritispathologyangiotensin-converting enzyme inhibitorangiotensin II receptor blocker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
M. E. Ougaard H. E. Jensen I. D. Thuen E. G. Petersen P. H. Kvist |
spellingShingle |
M. E. Ougaard H. E. Jensen I. D. Thuen E. G. Petersen P. H. Kvist Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis Renal Failure Nephrotoxic serum nephritis pathology angiotensin-converting enzyme inhibitor angiotensin II receptor blocker |
author_facet |
M. E. Ougaard H. E. Jensen I. D. Thuen E. G. Petersen P. H. Kvist |
author_sort |
M. E. Ougaard |
title |
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis |
title_short |
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis |
title_full |
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis |
title_fullStr |
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis |
title_full_unstemmed |
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis |
title_sort |
inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis |
publisher |
Taylor & Francis Group |
series |
Renal Failure |
issn |
0886-022X 1525-6049 |
publishDate |
2018-10-01 |
description |
Introduction: Chronic kidney disease (CKD) is a global health concern, but the current treatments only slow down the progression. Thus an improved understanding of the pathogenesis and novel treatments of CKD are needed. The nephrotoxic nephritis (NTN) model has the potential to study the pathogenesis of CKD as it resembles human CKD. The classical treatments with angiotensin II receptor blocker (ARB) or the angiotensin-converting enzyme inhibitor (ACE I) have shown a clinical effect in CKD. Methods: We characterized the disease development in the NTN model over 11 weeks by investigating functional and histopathological changes. We tested doses of 15 and 30 mg/kg/day enalapril and losartan in the NTN model in order to investigate the effect of inhibiting the renin-angiotensin-system (RAS). Results: The NTN model displayed albuminuria peaking on days 6–7, mesangial expansion (ME), renal fibrosis, inflammation and iron accumulation peaking on day 42. However, albuminuria, ME, renal fibrosis and inflammation were still significantly present on day 77, suggesting that the NTN model is useful for studying both the acute and chronic disease phases. Enalapril and losartan significantly enhanced the glomerular filtration rate (GFR) and decreased albuminuria, ME, renal fibrosis and inflammation of NTN-induced kidney disease in mice. Conclusions: This is the first study showing a comprehensive pathological description of the chronic features of the murine NTN model and that inhibiting the RAS pathway show a significant effect on functional and morphological parameters. |
topic |
Nephrotoxic serum nephritis pathology angiotensin-converting enzyme inhibitor angiotensin II receptor blocker |
url |
http://dx.doi.org/10.1080/0886022X.2018.1533867 |
work_keys_str_mv |
AT meougaard inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis AT hejensen inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis AT idthuen inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis AT egpetersen inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis AT phkvist inhibitorsofthereninangiotensinsystemamelioratesclinicalandpathologicalaspectsofexperimentallyinducednephrotoxicserumnephritis |
_version_ |
1725019586605088768 |